Cargando…

DePARylation is critical for S phase progression and cell survival

Poly(ADP-ribose)ylation or PARylation by PAR polymerase 1 (PARP1) and dePARylation by poly(ADP-ribose) glycohydrolase (PARG) are equally important for the dynamic regulation of DNA damage response. PARG, the most active dePARylation enzyme, is recruited to sites of DNA damage via pADPr-dependent and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nie, Litong, Wang, Chao, Huang, Min, Liu, Xiaoguang, Feng, Xu, Tang, Mengfan, Li, Siting, Hang, Qinglei, Teng, Hongqi, Shen, Xi, Ma, Li, Gan, Boyi, Chen, Junjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418084/ https://www.ncbi.nlm.nih.gov/pubmed/37577639 http://dx.doi.org/10.1101/2023.07.31.551317

Ejemplares similares

Targeting dePARylation for cancer therapy
por: Kassab, Muzaffer Ahmad, et al.
Publicado: (2020)

Targeting dePARylation selectively suppresses DNA repair–defective and PARP inhibitor–resistant malignancies
por: Chen, Shih-Hsun, et al.
Publicado: (2019)

USP7 substrates identified by proteomics analysis reveal the specificity of USP7
por: Nie, Litong, et al.
Publicado: (2022)

Coupling bimolecular PARylation biosensors with genetic screens to identify PARylation targets
por: Krastev, Dragomir B., et al.
Publicado: (2018)

Non-canonical function of DGCR8 in DNA double-strand break repair signaling and tumor radioresistance
por: Hang, Qinglei, et al.
Publicado: (2021)

Functions of PARylation in DNA Damage Repair Pathways
por: Wei, Huiting, et al.
Publicado: (2016)

PARP Inhibitors as Therapeutics: Beyond Modulation of PARylation
por: Min, Ahrum, et al.
Publicado: (2020)

SPINDOC binds PARP1 to facilitate PARylation
por: Yang, Fen, et al.
Publicado: (2021)

NAMPT and PARylation Are Involved in the Pathogenesis of Atopic Dermatitis
por: Arroyo, Ana B., et al.
Publicado: (2023)

SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells
por: Yan, Yuelong, et al.
Publicado: (2023)

A Double-Edged Sword: The Two Faces of PARylation
por: Kang, Mincheol, et al.
Publicado: (2022)

NUPR1 protects against hyperPARylation-dependent cell death
por: Santofimia-Castaño, Patricia, et al.
Publicado: (2022)

PARylation During Transcription: Insights into the Fine-Tuning Mechanism and Regulation
por: Páhi, Zoltán G., et al.
Publicado: (2020)

Chrysophanol protects against doxorubicin-induced cardiotoxicity by suppressing cellular PARylation
por: Lu, Jing, et al.
Publicado: (2019)

PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O(6)-methylguanine DNA damage in glioblastoma
por: Wu, Shaofang, et al.
Publicado: (2021)

DNA-PKcs PARylation regulates DNA-PK kinase activity in the DNA damage response
por: Han, Yang, et al.
Publicado: (2019)

Integrated screens uncover a cell surface tumor suppressor gene KIRREL involved in Hippo pathway
por: Wang, Chao, et al.
Publicado: (2022)

Genome-Wide CRISPR Screens Reveal ZATT as a Synthetic Lethal Target of TOP2-Poison Etoposide That Can Act in a TDP2-Independent Pathway
por: Park, Jeong-Min, et al.
Publicado: (2023)

The Enigmatic Function of PARP1: From PARylation Activity to PAR Readers
por: Kamaletdinova, Tatiana, et al.
Publicado: (2019)

TET-mediated DNA hydroxymethylation is negatively influenced by the PARP-dependent PARylation
por: Tolić, Anja, et al.
Publicado: (2022)

Mammalian N1-adenosine PARylation is a reversible DNA modification
por: Musheev, Michael U., et al.
Publicado: (2022)

Genetic vulnerabilities upon inhibition of DNA damage response
por: Wang, Chao, et al.
Publicado: (2021)

5mC-hydroxylase activity is influenced by the PARylation of TET1 enzyme
por: Ciccarone, Fabio, et al.
Publicado: (2015)

SUMOylation and PARylation cooperate to recruit and stabilize SLX4 at DNA damage sites
por: González-Prieto, Román, et al.
Publicado: (2015)

Real-time monitoring of PARP1-dependent PARylation by ATR-FTIR spectroscopy
por: Krüger, Annika, et al.
Publicado: (2020)

Histone Parylation factor 1 contributes to the inhibition of PARP1 by cancer drugs
por: Rudolph, Johannes, et al.
Publicado: (2021)

Structure and dynamics of the chromatin remodeler ALC1 bound to a PARylated nucleosome
por: Bacic, Luka, et al.
Publicado: (2021)

Increased PARylation impacts the DNA methylation process in type 2 diabetes mellitus
por: Zampieri, Michele, et al.
Publicado: (2021)

New insight into the significance of KLF4 PARylation in genome stability, carcinogenesis, and therapy
por: Zhou, Zhuan, et al.
Publicado: (2020)

PARP1-mediated PARylation activity is essential for oligodendroglial differentiation and CNS myelination
por: Wang, Yan, et al.
Publicado: (2021)

PARP1 mediated PARylation contributes to myogenic progression and glucocorticoid transcriptional response
por: Tan, Arnold, et al.
Publicado: (2023)

mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation
por: Zhang, Yilei, et al.
Publicado: (2021)

PARylation prevents the proteasomal degradation of topoisomerase I DNA-protein crosslinks and induces their deubiquitylation
por: Sun, Yilun, et al.
Publicado: (2021)

ZNF432 stimulates PARylation and inhibits DNA resection to balance PARPi sensitivity and resistance
por: O’Sullivan, Julia, et al.
Publicado: (2023)

Muscle PARP1 inhibition extends lifespan through AMPKα PARylation and activation in Drosophila
por: Guo, Shanshan, et al.
Publicado: (2023)

PC4-mediated Ku complex PARylation facilitates NHEJ-dependent DNA damage repair
por: Pan, Qimei, et al.
Publicado: (2023)

Extracellular signal-regulated kinases associate with and phosphorylate DHPS to promote cell proliferation
por: Wang, Chao, et al.
Publicado: (2020)

Interactomes of SARS‐CoV‐2 and human coronaviruses reveal host factors potentially affecting pathogenesis
por: Chen, Zhen, et al.
Publicado: (2021)

Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors
por: Feng, Xu, et al.
Publicado: (2022)

The cross-talk between PARylation and SUMOylation in C/EBPβ at K134 site participates in pathological cardiac hypertrophy
por: Wang, Luping, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bqbv6ufecd0us0pbbvvlirt9k0